A multi-centre long-term follow-up study of patients with low-grade non-Hodgkin's lymphoma previously treated with iodine I 131 tositumomab in studies CP-97-011, CP-98-025, CP-99-032, or CP-99-036

Trial Profile

A multi-centre long-term follow-up study of patients with low-grade non-Hodgkin's lymphoma previously treated with iodine I 131 tositumomab in studies CP-97-011, CP-98-025, CP-99-032, or CP-99-036

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Feb 2016

At a glance

  • Drugs Iodine-131 tositumomab (Primary)
  • Indications Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top